MIRA Pharmaceuticals, Inc.

0.72 USD
+0.01 (+1.07%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

MIRA Pharmaceuticals, Inc. stock is down -17.64% since 30 days ago. The next earnings date is Sep 13, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 1 June’s closed higher than May.

About MIRA Pharmaceuticals, Inc.

We are an early pre-clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic THC analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. Our corporate headquarters is located at 855 N Wolfe Street, Suite 601, Baltimore, Maryland.